共 25 条
[11]
KANTELIP JP, 1991, THERAPIE, V46, P475
[12]
EVALUATION OF POTENTIAL CAUSES FOR THE INCOMPLETE BIOAVAILABILITY OF FUROSEMIDE - GASTRIC 1ST-PASS METABOLISM
[J].
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS,
1983, 11 (06)
:623-640
[13]
GAS-CHROMATOGRAPHIC DETERMINATION OF FUROSEMIDE IN PLASMA USING AN EXTRACTIVE ALKYLATION TECHNIQUE AND AN ELECTRON-CAPTURE DETECTOR
[J].
JOURNAL OF CHROMATOGRAPHY,
1974, 101 (01)
:219-221
[14]
MACMACHON FG, 1983, EUR J CLIN PHARMACOL, V24, P791
[15]
AUTOMATED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF FUROSEMIDE IN DOG PLASMA
[J].
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS,
1993, 617 (02)
:339-343
[17]
PONTO LLB, 1990, CLIN PHARMACOKINET, V18, P381
[18]
IMPROVED METHOD FOR THE ANALYSIS OF FUROSEMIDE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
[J].
JOURNAL OF CHROMATOGRAPHY,
1982, 227 (02)
:463-469
[20]
RAPID HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION WITH FLUORESCENCE DETECTION OF FUROSEMIDE IN HUMAN-BODY FLUIDS AND ITS CONFIRMATION BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY
[J].
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS,
1991, 564 (02)
:567-578